Nils Confer
About Nils Confer
Nils Confer serves as the Vice President of Medical Affairs at BridgeBio, a position he has held since 2021. He has an extensive background in medical affairs and biomedical sciences, with previous roles at several pharmaceutical companies and a strong academic foundation.
Work at BridgeBio
Nils Confer has served as the Vice President of Medical Affairs at BridgeBio since 2021. In this role, he oversees medical strategies and initiatives that align with the company's mission to develop medicines for genetic diseases. His responsibilities include collaborating with cross-functional teams to ensure that clinical data is effectively communicated and utilized in decision-making processes.
Education and Expertise
Nils Confer holds a Bachelor of Science in Biology from Butler University, which he attended from 1995 to 1997. He furthered his education at the University of North Texas, where he earned a PhD in Biomedical Sciences with a focus on Biochemistry from 1999 to 2004. Additionally, he completed an MBA with a Graduate Certificate in Asian Business Studies at The University of Texas at Arlington from 2008 to 2009.
Background
Nils Confer has a diverse professional background that includes military service in the United States Marine Corps from 1989 to 1994. He began his career as a Quality Control Scientist at PepsiCo from 1997 to 1998. His experience spans various roles in medical affairs across multiple pharmaceutical companies, including Novartis, Shire Pharmaceuticals, and Raptor Pharmaceuticals.
Career Progression
Nils Confer has held several key positions in the pharmaceutical industry. After his tenure at PepsiCo, he worked as a Research Associate at UT Southwestern Medical Center from 2004 to 2005. He then transitioned to Novartis as a Medical Affairs professional from 2005 to 2010, followed by a role at Shire Pharmaceuticals from 2010 to 2014. He continued to advance his career at Raptor Pharmaceuticals and Horizon before joining Origin Biosciences in 2018 and BridgeBio in 2021.